- Home
- CII vs ETON Comparison
CII vs ETON Comparison
Compare CII & ETON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CII | ETON |
|---|---|---|
| Founded | 2004 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Bankers/Brokers/Service | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 872.7M |
| IPO Year | N/A | 2018 |
Fundamental Metrics
Financial Performance| Metric | CII | ETON |
|---|---|---|
| Price | $25.74 | $36.57 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $39.33 |
| AVG Volume (30 Days) | 61.2K | ★ 405.5K |
| Earning Date | 01-01-0001 | 05-14-2026 |
| Dividend Yield | ★ 6.17% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.05 |
| Revenue | N/A | ★ $79,950,000.00 |
| Revenue This Year | N/A | $40.90 |
| Revenue Next Year | N/A | $47.23 |
| P/E Ratio | ★ N/A | $746.60 |
| Revenue Growth | N/A | ★ 104.94 |
| 52 Week Low | $20.43 | $13.76 |
| 52 Week High | $26.17 | $38.62 |
Technical Indicators
Market Signals| Indicator | CII | ETON |
|---|---|---|
| Relative Strength Index (RSI) | 60.28 | 60.58 |
| Support Level | $23.04 | $15.77 |
| Resistance Level | $26.14 | N/A |
| Average True Range (ATR) | 0.46 | 1.58 |
| MACD | 0.04 | 0.03 |
| Stochastic Oscillator | 78.53 | 67.41 |
Price Performance
Historical ComparisonAbout CII Blackrock Capital and Income Fund Inc.
Blackrock Enhanced Cap&Inc Fund, Inc is a closed-end management investment company. Its investment objective is to provide current income and capital appreciation. The trust seeks to achieve its investment objective by investing in a portfolio of equity securities of U.S. and foreign issuers. It may invest directly in such securities or synthetically through the use of derivatives. It also seeks to achieve its investment objective by employing a writing (selling) call and put options.
About ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has eight commercial rare disease products, INCRELEX, ALKINDI SPRINKLE, KHINDIVITM, GALZIN, PKU GOLIKE, Carglumic Acid, Betaine Anhydrous and Nitisinone. It also has five additional product candidates in late-stage development: ET-600, Amglidia, ET-700, ET-800 and ZENEO hydrocortisone autoinjector.